Er:YAG Laser for Treatment of Enlarged Pores

Enlarged Pores Clinical Trial

Official title: The Efficacy and Safety of Erbium:Yttrium Aluminum Garnet Laser for Treatment of Enlarged Pores: A Pilot Study

Status Active, not recruiting

Clinical Trial Summary

To investigate the efficacy of Erbium:Yttrium aluminum garnet laser (Er:YAG) in the treatment of enlarged pores.

Clinical Trial Description

• Enlarged pores are caused by multifactorial factors such as sex, genetics, aging, etc.

• The gold of the treatment is to recollagenesis of the dermis and resurfacing of the epidermis.

• Modalities that have been proved on their efficacy for enlarged pores treatment included topical retinoic acid, chemical peeling, intense pulsed light, radiofrequency device, laser such as Q-switched and Long Pulsed Neodymium-Doped Yttrium-Aluminum-Garnet (Nd:YAG) 1,064nm, Long pulse duration pulsed dye laser 595nm, etc.

• Er:YAG laser is an ablative laser which creates both recollagenesis and resurfacing. It ha been proved to be safe and effective in the treatment of atrophic acne scar.

• However, the efficacy of this laser for enlarged treatment has not yet been established. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Enlarged Pores

• NCT number: NCT02544958
• Study type: Interventional
• Source: Mahidol University
• Status: Active, not recruiting
• Phase: N/A
• Start date: May 2015
• Completion date: August 2016